Skip to results
Modify your search
NARROW
1-8 of 8
Keywords: pheochromocytomas
Sort by
Journal Article
Adrenal Tumors in Children and Adolescents in Sweden: A Register-Based Study Covering 15 Years
Eleni Terezaki and others
Journal of the Endocrine Society, Volume 9, Issue 5, May 2025, bvaf058, https://doi.org/10.1210/jendso/bvaf058
Published: 02 April 2025
... pathology (ganglioneuroblastoma, n = 1), or were patients with pheochromocytoma (n = 12) with a follow-up of less than 10 years. There was no difference in sex distribution between patients with malignant and benign ATs. Patients with malignant ATs were younger compared to patients with benign ATs (2 years...
Journal Article
Pitfalls in the Diagnostic Evaluation of Pheochromocytomas
Gustavo F C Fagundes and Madson Q Almeida
Journal of the Endocrine Society, Volume 8, Issue 6, June 2024, bvae078, https://doi.org/10.1210/jendso/bvae078
Published: 08 May 2024
... for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected]. Abstract Pheochromocytomas and paragangliomas (PPGLs), rare neuroendocrine tumors arising from...
Journal Article
Platelet-Lymphocyte and Neutrophil-Lymphocyte Ratios Are Prognostic Markers for Pheochromocytomas and Paragangliomas
Xu Zhong and others
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 9, September 2023, Pages 2230–2239, https://doi.org/10.1210/clinem/dgad149
Published: 14 March 2023
... (LMR), have recently been proposed as prognostic markers in different tumors. However, their predictive values in patients with pheochromocytomas and paragangliomas (PPGLs) are uncertain. Objective This study aimed to investigate the prognostic significance of inflammatory biomarkers in PPGL...
Journal Article
Efficacy and Safety of Tyrosine Kinase Inhibitors in Patients with Metastatic Pheochromocytomas/Paragangliomas
Yue Zhou and others
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 3, March 2023, Pages 755–766, https://doi.org/10.1210/clinem/dgac657
Published: 16 November 2022
... or “pheochromocytomas” or “paragangliomas” as “Populations” and 48 TKIs or their related synonyms as “Intervention” using “PICOS” principles to search the following 5 databases: PubMed, EMBASE, Cochrane Library, Scopus, and Clinical Trial without published time and language limitations. The detailed search strategy...
Journal Article
Perioperative Management of Pheochromocytomas and Sympathetic Paragangliomas
Gustavo F C Fagundes and Madson Q Almeida
Journal of the Endocrine Society, Volume 6, Issue 2, February 2022, bvac004, https://doi.org/10.1210/jendso/bvac004
Published: 14 January 2022
... in pheochromocytomas and Cluster 1B tumors [ 14 , 42 ] All patients with pheochromocytomas and sympathetic paragangliomas should benefit from adequate preoperative clinical care [ 43 ]. Nevertheless, this clinical management has a low quality of evidence with few prospective trials. The evidence is mainly based...
Chapter
The Posterior Pituitary and Water Metabolism
Get access
Willis K Samson
Published: 15 December 2011
... portions of the internal carotid artery. Adrenomedullins Arginine vasopressin (AVP) Atrial natriuretic peptides (ANPs) Estrogen-stimulated neurophysin Pheochromocytomas (adrenal medulla tumor) Proadrenomedullin N-terminal Renin-angiotensin system Transforming growth factor-beta (TGF-beta...
Chapter
Familial CNS Tumor Syndromes: Von Hippel-Lindau Disease
Get access
Gurvinder Kaur and others
Published: 01 August 2016
... of these tumors; specifically within those patients with this genetic disorder. autosomal dominant Von Hippel-Lindau hemangioblastomas retinal hemangioblastomas pheochromocytomas VHL tumor suppressor gene hypoxia inducible factor (HIF) VEGF (vascular endothelial growth factor) Familial central nervous...
Chapter
Active Pheochromacytoma
Get access
Vilma Joseph and Chukwuemeka Okafor
Published: 01 October 2018
...Oxford University Press Pheochromocytomas present themselves as a management challenge not only to anesthesiologists but to surgeons and nonoperative medical professionals. From determining the initial diagnosis to its removal, the effects this tumor has on the body must be appreciated...
Advertisement
Advertisement